Comprehensive Chronic
Diseases & Reversal Directory
Explore our evidence-based, physician-led clinical protocols for managing, stabilizing, and reversing chronic metabolic, cardiovascular, respiratory, renal, and musculoskeletal conditions.
High Blood Pressure (Hypertension)
I10 - Essential (primary) hypertension
Hypertension is a silent, progressive chronic condition where the force of blood against arterial walls remains persistently elevated (>= 130/80 mmHg), accelerating arterial stiffening, stroke, heart failure, and renal decline.
Affects over 31% of urban and 27% of rural adults in North India.
Target BP Range
< 120/80 mmHg
Stroke Risk Reduction
Up to 40%
Medication Taper Rate
67% within 90 days
Type 2 Diabetes & Prediabetes
E11 - Type 2 diabetes mellitus
Type 2 Diabetes is a progressive metabolic disorder where cells become resistant to insulin, causing chronically elevated blood glucose that silently damages blood vessels, nerves, kidneys, and eyes.
Over 101 million people in India are diabetic, with 136 million prediabetic.
Remission Rate
78.4%
HbA1c Target
< 6.0%
Insulin Discontinuation
82% in 12 Weeks
Thyroid Disorders (Hypo & Hyperthyroidism)
E03.9 - Hypothyroidism, unspecified
Thyroid dysfunction impairs metabolic rate, energy production, body temperature, and mood. We specialize in root-cause autoantibody assessment, T3/T4 conversion, and endocrine restoration.
1 in 8 Indian women suffers from thyroid dysfunction, predominantly hypothyroidism.
Autoimmune Identification
92% in Clinic
Energy Score Improvement
+85% in 60 Days
Optimal TSH Target
1.0 - 2.5 mIU/L
Heart Disease & Preventive Cardiology
I25.1 - Atherosclerotic heart disease
Coronary artery disease is driven by endothelial inflammation and arterial plaque. Our preventive cardiology program stabilizes plaque, improves ejection fraction, and reverses cardiovascular risk.
Indians develop CAD 10 years earlier than Western populations; 28% of all deaths in India.
Angina Free Rate
84% in 90 Days
ApoB Reduction Target
< 60 mg/dL
Exercise Capacity
+45% in 12 Weeks
COPD (Chronic Obstructive Pulmonary Disease)
J44.9 - Chronic obstructive pulmonary disease, unspecified
COPD progressively destroys lung tissue, trapping air and reducing oxygen exchange. Our pulmonary rehabilitation program slows decline, reduces exacerbations, and improves breathing capacity.
Second leading cause of death in India; affects over 55 million Indians.
Exacerbation Reduction
55% Fewer/Year
FEV1 Improvement
+18% in 90 Days
6-Min Walk Distance
+85 Meters
Chronic Bronchial Asthma
J45.9 - Asthma, unspecified
Bronchial asthma involves chronic airway inflammation with episodic bronchoconstriction. Our protocol identifies triggers, reduces steroid dependency, and improves peak flow.
Over 38 million asthma patients in India, accounting for 42% of global asthma deaths.
Rescue Inhaler Reduction
72% Less Usage
Peak Flow Improvement
+35% in 8 Weeks
Steroid Taper Success
68% of Patients
Chronic Kidney Disease (Early Stages & Preservation)
N18 - Chronic kidney disease
CKD silently erodes kidney filtration. Our renal preservation program halts decline in early stages through metabolic optimization, BP control, and nephroprotective strategies.
Affects over 17% of the Indian population; major cause of end-stage morbidity.
eGFR Stabilization
89% of Patients
Dialysis Prevention
94% at Stage 3
Target Proteinuria
< 300 mg/day
Fatty Liver Disease (NAFLD / MASLD)
K76.0 - Non-alcoholic fatty liver disease
Non-alcoholic fatty liver (MASLD) is ectopic fat deposition in hepatocytes driven by insulin resistance, progressing silently to inflammation (NASH), fibrosis, and cirrhosis.
Affects over 38% of Indian adults, with over 55% prevalence in diabetic individuals.
Fat Reduction Rate
71% in 90 Days
ALT Normalization
88% of Patients
Fibrosis Prevention
95% at Grade I-II
Arthritis & Chronic Joint Care
M19.9 - Osteoarthritis, unspecified
Degenerative arthritis progressively destroys cartilage. Our non-surgical joint preservation program combines targeted supplements, physiotherapy, and weight optimization to reduce pain and restore mobility.
Over 180 million Indians suffer from arthritis; 1 in 4 elderly adults affected.
Pain Score Reduction
76% Avg. Decrease
Surgery Avoidance
81% of Patients
Mobility Improvement
+60% in 12 Weeks
Obesity & Metabolic Syndrome
E66.9 - Obesity, unspecified
Metabolic syndrome is a cluster of visceral obesity, insulin resistance, dyslipidemia, and hypertension that dramatically amplifies cardiovascular and diabetic risk.
Affects over 30% of adult urban Indians; massive driver of premature cardiometabolic disease.
Visceral Fat Reduction
38% in 90 Days
Metabolic Markers Normalized
74%
Sustainable Weight Loss
8-12 kg in 90 Days
High Cholesterol & Dyslipidemia
E78.5 - Dyslipidemia, unspecified
Dyslipidemia accelerates atherosclerosis through elevated LDL, triglycerides, and low HDL. Our lipid optimization program targets ApoB and achieves plaque stabilization.
Over 79% of urban Indians have at least one abnormal lipid parameter (high TG or low HDL).
LDL Reduction
42% Average
ApoB Target Achievement
78%
Triglyceride Normalization
85% in 60 Days
Chronic Migraine & Tension Headaches
G43.9 - Migraine, unspecified
Chronic migraine involves recurrent neurovascular attacks with debilitating pain, nausea, and sensitivity. Our protocol identifies metabolic, hormonal, and cervicogenic triggers.
Affects over 213 million Indians; #1 cause of disability in individuals aged 15-49.
Attack Frequency Reduction
65% Fewer/Month
Pain Intensity Decrease
58% Average
Medication Overuse Resolved
72%
Osteoporosis & Bone Health
M81.0 - Age-related osteoporosis
Osteoporosis silently weakens bones, increasing fracture risk. Our bone density preservation program combines targeted nutrition, weight-bearing exercise, and pharmacotherapy.
Over 50 million Indians have osteoporosis or severely low bone mass (osteopenia).
Bone Density Improvement
+4.2% T-Score/Year
Fracture Risk Reduction
52%
Calcium Absorption Optimized
88%
PCOS / PCOD (Polycystic Ovary Syndrome)
E28.2 - Polycystic ovarian syndrome
PCOS is a hormonal disorder driven by insulin resistance causing irregular periods, excess androgens, acne, and infertility. Our protocol targets the metabolic root cause.
Affects 1 in 5 Indian women of reproductive age; rapidly rising in urban centers.
Cycle Regularity Restored
81% in 90 Days
Androgen Normalization
74%
Insulin Sensitivity
+62% Improvement
Chronic Anemia & Nutritional Deficiencies
D64.9 - Anemia, unspecified
Chronic anemia and micronutrient deficiencies (iron, B12, folate, vitamin D) cause fatigue, cognitive impairment, and immune dysfunction. Our protocol identifies root absorption issues.
Affects over 57% of Indian women and 25% of men (NFHS-5 data).
Hemoglobin Normalization
91% in 60 Days
Fatigue Score Improvement
+78%
Deficiency Resolution
94%
Sleep Apnea & Chronic Sleep Disorders
G47.3 - Sleep apnea
Obstructive sleep apnea disrupts breathing during sleep, causing oxygen desaturation, daytime fatigue, and cardiovascular strain. Our program includes polysomnography and targeted interventions.
Affects over 104 million Indians, with over 80% remaining undiagnosed and untreated.
AHI Reduction
64% Average
Daytime Sleepiness Resolved
79%
BP Improvement from CPAP
12/8 mmHg Drop
Not Sure Which Protocol Fits Your Symptoms?
Take our 1-minute confidential screener to determine your cardiometabolic risk and recommended investigations.
1-Minute Chronic Health Risk Screener
Evidence-based assessment for Diabetes, Hypertension & Metabolic Risk
What is your current age bracket?
Chronic Care FAQs
Standard medical practice often focuses on symptom suppression—prescribing lifelong pills and continuously increasing dosages as the condition deteriorates. At Haryana Hospital, we practice Root-Cause Metabolic Medicine: identifying and reversing cellular insulin resistance, chronic endothelial stiffness, ectopic organ fat, and gut-immune inflammation to restore organ function and safely taper or eliminate medication dependency.